{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:36:16Z","timestamp":1792290976522,"version":"4.4.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T00:00:00Z","timestamp":1680652800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T00:00:00Z","timestamp":1680652800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100015763","name":"University of Szeged","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100015763","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Headache Pain"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      The glutamatergic neurotransmission has important role in the pathomechanism of primary headache disorders. The kynurenine metabolites derived from catabolism of tryptophan (Trp) have significant involvement not only in glutamatergic processes, but also in the neuroinflammation, the oxidative stress and the mitochondrial dysfunctions. Previously we identified a depressed peripheral Trp metabolism in interictal period of episodic migraineurs, which prompted us to examine this pathway in patients with episodic cluster headache (CH) as well. Our aims were to compare the concentrations of compounds both in headache-free and attack periods, and to find correlations between Trp metabolism and the clinical features of CH. Levels of 11 molecules were determined in peripheral blood plasma of healthy controls (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200922) and interbout\/ictal periods of CH patients (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200924) by neurochemical measurements.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Findings<\/jats:title>\n                    <jats:p>\n                      Significantly decreased L-kynurenine (KYN,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.01), while increased quinolinic acid (QUINA,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.005) plasma concentrations were detected in the interbout period of CH patients compared to healthy subjects. The levels of KYN are further reduced during the ictal period compared to the controls (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.006). There was a moderate, negative correlation between disease duration and interbout QUINA levels (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.048,\n                      <jats:italic>R<\/jats:italic>\n                      \u2009=\u2009\u2009\u2212\u20090.459); and between the total number of CH attacks experienced during the lifetime of patients and the interbout KYN concentrations (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.024,\n                      <jats:italic>R<\/jats:italic>\n                      \u2009=\u2009\u2009\u2212\u20090.516). Linear regression models revealed negative associations between age and levels of Trp, kynurenic acid, 3-hdyroxyanthranilic acid and QUINA in healthy control subjects, as well as between age and ictal level of anthranilic acid.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our results refer to a specifically altered Trp metabolism in CH patients. The onset of metabolic imbalance can be attributed to the interbout period, where the decreased KYN level is unable to perform its protective functions, while the concentration of QUINA, as a toxic compound, increases. These processes can trigger CH attacks, which may be associated with glutamate excess induced neurotoxicity, neuroinflammation and oxidative stress. Further studies are needed to elucidate the exact functions of these molecular alterations that can contribute to identify new, potential biomarkers in the therapy of CH.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s10194-023-01570-9","type":"journal-article","created":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T19:04:04Z","timestamp":1680635044000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Cluster headache and kynurenines"],"prefix":"10.1186","volume":"24","author":[{"given":"Bernadett","family":"Tuka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tam\u00e1s","family":"K\u00f6rt\u00e9si","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolett","family":"N\u00e1n\u00e1si","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferenc","family":"T\u00f6m\u00f6si","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tam\u00e1s","family":"Jan\u00e1ky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00e1niel","family":"Ver\u00e9b","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00e9lia","family":"Szok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e1nos","family":"Tajti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e1szl\u00f3","family":"V\u00e9csei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,5]]},"reference":[{"issue":"1","key":"1570_CR1","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S1474-4422(17)30405-2","volume":"17","author":"J Hoffmann","year":"2018","unstructured":"Hoffmann J, May A (2018) Diagnosis, pathophysiology, and management of cluster headache. Lancet Neurol 17(1):75\u201383","journal-title":"Lancet Neurol"},{"issue":"4, Headache","key":"1570_CR2","first-page":"1137","volume":"24","author":"M Burish","year":"2018","unstructured":"Burish M (2018) Cluster headache and other trigeminal autonomic cephalalgias. Continuum (Minneap Minn) 24(4, Headache):1137\u201356","journal-title":"Continuum (Minneap Minn)"},{"issue":"Supplement","key":"1570_CR3","doi-asserted-by":"crossref","first-page":"S124","DOI":"10.4103\/0028-3886.315983","volume":"69","author":"S Cheema","year":"2021","unstructured":"Cheema S, Matharu M (2021) Cluster headache: what\u2019s new? Neurol India 69(Supplement):S124\u2013S134","journal-title":"Neurol India"},{"issue":"1","key":"1570_CR4","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s10194-020-01098-2","volume":"21","author":"LH Schulte","year":"2020","unstructured":"Schulte LH, Haji AA, May A (2020) Phase dependent hypothalamic activation following trigeminal input in cluster headache. J Headache Pain 21(1):30","journal-title":"J Headache Pain"},{"issue":"5","key":"1570_CR5","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/s41582-021-00477-w","volume":"17","author":"DY Wei","year":"2021","unstructured":"Wei DY, Goadsby PJ (2021) Cluster headache pathophysiology - insights from current and emerging treatments. Nat Rev Neurol 17(5):308\u2013324","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"1570_CR6","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1136\/jnnp.50.2.207","volume":"50","author":"E Waldenlind","year":"1987","unstructured":"Waldenlind E, Gustafsson SA, Ekbom K, Wetterberg L (1987) Circadian secretion of cortisol and melatonin in cluster headache during active cluster periods and remission. J Neurol Neurosurg Psychiatry 50(2):207\u2013213","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"Pt 3","key":"1570_CR7","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1093\/brain\/117.3.427","volume":"117","author":"PJ Goadsby","year":"1994","unstructured":"Goadsby PJ, Edvinsson L (1994) Human in vivo evidence for trigeminovascular activation in cluster headache. Neuropeptide changes and effects of acute attacks therapies. Brain 117(Pt 3):427\u201334","journal-title":"Brain"},{"issue":"1","key":"1570_CR8","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s10194-016-0660-7","volume":"17","author":"B Tuka","year":"2016","unstructured":"Tuka B, Szab\u00f3 N, T\u00f3th E, Kincses ZT, P\u00e1rdutz \u00c1, Szok D et al (2016) release of PACAP-38 in episodic cluster headache patients - an exploratory study. J Headache Pain 17(1):69","journal-title":"J Headache Pain"},{"issue":"2","key":"1570_CR9","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s13311-018-0616-5","volume":"15","author":"J Hoffmann","year":"2018","unstructured":"Hoffmann J, Charles A (2018) Glutamate and its receptors as therapeutic targets for migraine. Neurotherapeutics 15(2):361\u2013370","journal-title":"Neurotherapeutics"},{"issue":"1","key":"1570_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.59566\/IJBS.2013.9001","volume":"9","author":"CF Gasparini","year":"2013","unstructured":"Gasparini CF, Griffiths LR (2013) The biology of the glutamatergic system and potential role in migraine. Int J Biomed Sci 9(1):1\u20138","journal-title":"Int J Biomed Sci"},{"issue":"11","key":"1570_CR11","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1177\/1060028014548872","volume":"48","author":"L Huang","year":"2014","unstructured":"Huang L, Bocek M, Jordan JK, Sheehan AH (2014) Memantine for the prevention of primary headache disorders. Ann Pharmacother 48(11):1507\u201311","journal-title":"Ann Pharmacother"},{"issue":"1","key":"1570_CR12","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/nrd3793","volume":"12","author":"L V\u00e9csei","year":"2013","unstructured":"V\u00e9csei L, Szal\u00e1rdy L, F\u00fcl\u00f6p F, Toldi J (2013) Kynurenines in the CNS: recent advances and new questions. Nat Rev Drug Discov 12(1):64\u201382","journal-title":"Nat Rev Drug Discov"},{"key":"1570_CR13","doi-asserted-by":"publisher","first-page":"745","DOI":"10.3389\/fneur.2017.00745","volume":"8","author":"T K\u00f6rt\u00e9si","year":"2017","unstructured":"K\u00f6rt\u00e9si T, Tuka B, Tajti J, Bagoly T, F\u00fcl\u00f6p F, Helyes Z et al (2017) Kynurenic acid inhibits the electrical stimulation induced elevated pituitary adenylate cyclase-activating polypeptide expression in the TNC. Front Neurol 8:745","journal-title":"Front Neurol"},{"issue":"1","key":"1570_CR14","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s10194-020-01105-6","volume":"21","author":"EK Cseh","year":"2020","unstructured":"Cseh EK, Veres G, K\u00f6rt\u00e9si T, Poly\u00e1k H, N\u00e1n\u00e1si N, Tajti J et al (2020) Neurotransmitter and tryptophan metabolite concentration changes in the complete Freund\u2019s adjuvant model of orofacial pain. J Headache Pain 21(1):35","journal-title":"J Headache Pain"},{"issue":"1","key":"1570_CR15","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s10194-021-01239-1","volume":"22","author":"B Tuka","year":"2021","unstructured":"Tuka B, Ny\u00e1ri A, Cseh EK, K\u00f6rt\u00e9si T, Ver\u00e9b D, T\u00f6m\u00f6si F et al (2021) Clinical relevance of depressed kynurenine pathway in episodic migraine patients: potential prognostic markers in the peripheral plasma during the interictal period. J Headache Pain 22(1):60","journal-title":"J Headache Pain"},{"key":"1570_CR16","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s10194-016-0620-2","volume":"17","author":"M Curto","year":"2015","unstructured":"Curto M, Lionetto L, Negro A, Capi M, Perugino F, Fazio F et al (2015) Altered serum levels of kynurenine metabolites in patients affected by cluster headache. J Headache Pain 17:27","journal-title":"J Headache Pain"},{"issue":"30","key":"1570_CR17","doi-asserted-by":"publisher","first-page":"6837","DOI":"10.1016\/j.febslet.2006.11.043","volume":"580","author":"LZ Yi","year":"2006","unstructured":"Yi LZ, He J, Liang YZ, Yuan DL, Chau FT (2006) Plasma fatty acid metabolic profiling and biomarkers of type 2 diabetes mellitus based on GC\/MS and PLS-LDA. FEBS Lett 580(30):6837\u201345","journal-title":"FEBS Lett"},{"issue":"3","key":"1570_CR18","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1148\/radiology.148.3.6878708","volume":"148","author":"JA Hanley","year":"1983","unstructured":"Hanley JA, McNeil BJ (1983) A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 148(3):839\u2013843","journal-title":"Radiology"},{"issue":"4","key":"1570_CR19","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/S0733-8619(18)30318-9","volume":"8","author":"MA Moskowitz","year":"1990","unstructured":"Moskowitz MA (1990) Basic mechanisms in vascular headache. Neurol Clin 8(4):801\u201315","journal-title":"Neurol Clin"},{"issue":"4","key":"1570_CR20","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1016\/S0306-4522(98)00536-3","volume":"90","author":"RJ Storer","year":"1999","unstructured":"Storer RJ, Goadsby PJ (1999) Trigeminovascular nociceptive transmission involves N-methyl-D-aspartate and non-N-methyl-D-aspartate glutamate receptors. Neuroscience 90(4):1371\u20131376","journal-title":"Neuroscience"},{"issue":"17","key":"1570_CR21","doi-asserted-by":"publisher","first-page":"6045","DOI":"10.3390\/ijms21176045","volume":"21","author":"F Jovanovic","year":"2020","unstructured":"Jovanovic F, Candido KD, Knezevic NN (2020) The role of the kynurenine signaling pathway in different chronic pain conditions and potential use of therapeutic agents. Int J Mol Sci 21(17):6045","journal-title":"Int J Mol Sci"},{"issue":"14","key":"1570_CR22","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1177\/0333102419851815","volume":"39","author":"WC Naber","year":"2019","unstructured":"Naber WC, Fronczek R, Haan J, Doesborg P, Colwell CS, Ferrari MD et al (2019) The biological clock in cluster headache: a review and hypothesis. Cephalalgia 39(14):1855\u201366","journal-title":"Cephalalgia"},{"issue":"3","key":"1570_CR23","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1177\/0333102419883372","volume":"40","author":"MJ Lee","year":"2020","unstructured":"Lee MJ, Cho SJ, Park JW, Chu MK, Moon HS, Chung PW et al (2020) Temporal changes of circadian rhythmicity in cluster headache. Cephalalgia 40(3):278\u2013287","journal-title":"Cephalalgia"},{"issue":"3","key":"1570_CR24","doi-asserted-by":"publisher","first-page":"295","DOI":"10.3109\/09513598709023616","volume":"1","author":"E Martignoni","year":"1987","unstructured":"Martignoni E, Sances G, Nappi G (1987) Significance of hormonal changes in migraine and cluster headache. Gynecol Endocrinol 1(3):295\u2013319","journal-title":"Gynecol Endocrinol"},{"issue":"6","key":"1570_CR25","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/j.1468-2982.2005.00889.x","volume":"25","author":"MFP Peres","year":"2005","unstructured":"Peres MFP (2005) Melatonin, the pineal gland and their implications for headache disorders. Cephalalgia 25(6):403\u2013411","journal-title":"Cephalalgia"},{"issue":"18","key":"1570_CR26","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1212\/WNL.0000000000003282","volume":"87","author":"MA Louter","year":"2016","unstructured":"Louter MA, Wilbrink LA, Haan J, van Zwet EW, van Oosterhout WPJ, Zitman FG et al (2016) Cluster headache and depression. Neurology 87(18):1899\u2013906","journal-title":"Neurology"},{"issue":"4","key":"1570_CR27","doi-asserted-by":"publisher","first-page":"18006","DOI":"10.1038\/nrdp.2018.6","volume":"1","author":"A May","year":"2018","unstructured":"May A, Schwedt TJ, Magis D, Pozo-Rosich P, Evers S, Wang SJ (2018) Cluster headache. Nat Rev Dis Primers 1(4):18006","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"1570_CR28","first-page":"24","volume":"105","author":"OO Malu","year":"2022","unstructured":"Malu OO, Bailey J, Hawks MK (2022) Cluster headache: rapid evidence review. Am Fam Physician 105(1):24\u201332","journal-title":"Am Fam Physician"},{"issue":"1","key":"1570_CR29","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/s41398-021-01610-5","volume":"11","author":"S Leclercq","year":"2021","unstructured":"Leclercq S, Schwarz M, Delzenne NM, St\u00e4rkel P, de Timary P (2021) Alterations of kynurenine pathway in alcohol use disorder and abstinence: a link with gut microbiota, peripheral inflammation and psychological symptoms. Transl Psychiatry 11(1):503","journal-title":"Transl Psychiatry"}],"container-title":["The Journal of Headache and Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-023-01570-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10194-023-01570-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-023-01570-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T14:32:45Z","timestamp":1729175565000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejournalofheadacheandpain.biomedcentral.com\/articles\/10.1186\/s10194-023-01570-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,5]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1570"],"URL":"https:\/\/doi.org\/10.1186\/s10194-023-01570-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2530250\/v1","asserted-by":"object"}]},"ISSN":["1129-2377"],"issn-type":[{"value":"1129-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,5]]},"assertion":[{"value":"30 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All patients enrolled in this study are treated as outpatients at the Department of Neurology, Albert Szent-Gy\u00f6rgyi Medical School and University of Szeged. Investigations were conducted after the approval of the local Ethical Committee of the University of Szeged (87\/2009) and the Department of Health Administration of National Public Health Centre (29022\u20135\/2019\/E\u00dcIG, 28324\u20135\/2019\/E\u00dcIG). All participants gave their written informed consent in accordance with the most recent revision of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have read and approved the final version of the manuscript. They agree to take public responsibility for its contents and consent for publication in The Journal of Headache and Pain. The work reported in the paper has not been published anywhere before.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"35"}}